Tenaya Therapeutics Appoints Eric Hyllengren as CFO

Management
โดย RTTNews·Read original
Summary · why it matters

Tenaya Therapeutics has appointed Eric Hyllengren as Chief Financial Officer, effective July 13. Hyllengren most recently served as CFO of Zura Bio and previously held the roles of CFO and Chief Operating Officer at Atara Biotherapeutics. Earlier in his career, he spent 15 years at Amgen in roles of increasing responsibility across finance, investor relations, and business development.

Impact on stocks 4

Biotech & Genomic Medicine▲ · 4 stocks
Tenaya Therapeutics Inc
TNYA
± MixedCapitalrelevance

Appointment of a new CFO is a management change; no clear positive or negative signal about company performance.

© 2026 MarketDXNews